15 results
8-K
EX-1.1
VKTX
Viking Therapeutics Inc
1 Mar 24
Viking Therapeutics Announces Pricing of $550 Million Public Offering of Common Stock
4:05pm
of such indemnified party unless (i) the indemnifying party and the indemnified party shall have mutually agreed in writing to the retention
S-3ASR
EX-4.2
VKTX
Viking Therapeutics Inc
26 Jul 23
Automatic shelf registration
5:26pm
, exchange, payment, replacement or cancellation and shall destroy such canceled Securities (subject to the record retention requirement of the Exchange Act
PRE 14A
VKTX
Viking Therapeutics Inc
17 Apr 23
Preliminary proxy
5:04pm
over financial reporting and any significant changes in internal controls;
establishing and overseeing procedures for the receipt, retention
8-K
EX-1.1
ej4w6yx2vjv61vm11
31 Mar 23
Viking Therapeutics Announces Pricing of $250 Million Public Offering of Common Stock
5:27pm
8-K
EX-10.1
cn1ito62526nrq
2 Aug 19
Entry into a Material Definitive Agreement
12:00am
424B4
9uzba0x gzz1
8 Apr 16
Prospectus supplement with pricing info
12:00am
- Prev
- 1
- Next